DIRS.INFO The most relevant business & tech news

☆ Cramer gives the portfolio's core holdings a makeover — 4 are booted, 6 are added including a trio of tech giants
▼ + stars: | 2024-02-28 | by ( Morgan Chittum | ) www.cnbc.com time to read: +12 min

COST 5Y mountain Costco's stock performance over the past five years. DHR 5Y mountain Danaher's stock performance over the past five years. ETN 5Y mountain Eaton Corp.'s stock performance over the past five years. "The megatrends are real serious, and [Eaton] is a real serious company," Jim said. TJX 5Y mountain TJX Companies' stock performance over the past five years.

Persons: Jim Cramer, Jeff Marks, Morgan Stanley, Wall, Beijing's, Jim, Eaton, Linde, Lilly's, Eli Lilly, We've, Zepbound, Mark Zuckerberg's, Mark Zuckerberg, OpenAI, Copilot, management's, Nvidia, TJ Maxx, TikTok, Gen Zers, TJX, Jim Cramer's, Satya Narayana Nadella, Lucas Jackson Organizations: GE Healthcare, Meta, Microsoft, Johnson, Natural Resources, Starbucks, Apple, Apple Music, Services, Amazon, Amazon Web Services, Prime, Costco, Danaher, Eaton Corp, Investors, GE, LIN, Novo Nordisk's Wegovy, Novo Nordisk, Management, Nvidia, TJX Companies, Marshalls, CNBC Locations: Eaton, China, Manhattan, New York City

☆ Here's a rapid-fire update on all 32 stocks in our portfolio, including Cramer's fave tech play
▼ + stars: | 2024-01-24 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +15 min

Here's a rapid-fire update on all the stocks in Jim Cramer's Charitable Trust, the portfolio we use for the CNBC Investing Club. Investors tend to assign a premium to software revenue because it is often recurring and higher margin than hardware. (See here for a full list of the stocks in Jim Cramer's Charitable Trust.) As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Jim Cramer's, Jim, downgrades, preorders, we've, Jim said, Salesforce, Baird, Dupont De, Dupont, Walt Disney, Nelson Peltz, Estee Lauder, Fabrizio Freda, We've, he's, it's, Locker, Mary, Vimal Kapur, Eli Lilly, Lilly, Meta's Ray, Morgan Stanley, Ted Pick, James Gorman, —, chipmaker, It's, hasn't, Stanley Black, Decker, Wells, Charlie Scharf, We'll, Jim Cramer, Jim Cramer Rob Kim Organizations: Jim Cramer's Charitable Trust, CNBC, Club, Apple, mojo, Vision Pro, Broadcom, VMWare, Bausch Health, Caterpillar, Dupont, Costco Wholesale, Coterra Energy, Dupont De Nemours, Disney, Eaton Corp, Ford, Holding, Federal Reserve, GE Healthcare, Wall, Google, Honeywell, Boeing, Airbus, Linde, Facebook, Microsoft, Nvidia, Alto Networks, Palo Alto, Procter & Gamble, Constellation Brands, Modelo, TJX, Wynn Resorts, We've, Wynn, Jim Cramer's Charitable Locations: China, Indonesia, Brazil, India, U.S, Shenzhen, We're, Eaton, Ford, That's, Palo, Palestine, Wells Fargo, Wynn, Macau

☆ Danaher's new acquisition is the latest sign the health-care firm is staging a quiet recovery
▼ + stars: | 2023-12-05 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +5 min

And with the company set to close a key acquisition this week, Danaher's stock is set up for a stronger 2024. On Tuesday, Danaher stock fell about 1.75%, to $218.25 per share. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Rainer Blair, Blair, Danaher, Jeff Marks, we've, Danaher's, Jim Cramer's, Jim Cramer, Jim, Igor Golovniov Organizations: British, Danaher, CNBC, Danaher Corporation, Lightrocket, Getty Locations: Danaher, Veralto

☆ These 10 stocks notched double-digit gains and outperformed the market in November
▼ + stars: | 2023-12-01 | by ( Morgan Chittum | ) www.cnbc.com time to read: +8 min

FL YTD mountain Foot Locker (FL) performance year-to-date Foot Locker (FL) climbed 28.3% during November, making it the Club's No. Foot Locker stock, down more than 26% year-to-date, closed 1.4% lower Thursday, at just under $27.28 apiece. CRM YTD mountain Salesforce (CRM) performance year-to-date Salesforce (CRM) shares jumped 25.4% in November, coming in second place for monthly gains. NVDA YTD mountain Nvidia (NVDA) performance year-to-date Nvidia (NVDA) — an "own it, don't trade it" name — was the portfolio's fifth-best performer in November. WFC YTD mountain Wells Fargo (WFC) performance year-to-date Shares of Wells Fargo (WFC) jumped 12.07% in November, as the broader market rally lifted financials.

Persons: Jim Cramer, Mary Dillon's, Locker, Palo, CrowdStrike, We're bullish, —, Wall, Walt Disney, Nelson Peltz's, Wells, Morgan Stanley, Sam Altman, OpenAI, Altman, Jim Cramer's, Jim, Michael M Organizations: —, Palo Alto Networks, Palo Alto, Management, Nvidia, DIS, Walt Disney, Disney, Oracle, Microsoft, CNBC, Traders, New York Stock Exchange, Santiago, Getty Locations: FL, Palo, Palo Alto, Wells, Wells Fargo, OpenAI, DHR

☆ Tuesday, Nov. 21, 2023: Cramer says it's 'too soon' to add shares to this megacap tech position
▼ + stars: | 2023-11-21 | by ( Sean Conlon | ) www.cnbc.com time to read: 1 min

Tuesday, Nov. 21, 2023: Cramer says it's 'too soon' to add shares to this megacap tech positionJim explains why he believes it's not yet the time to buy more shares of this megacap tech position in the Charitable Trust. Jim also discusses why the stock price of this life sciences holding can go higher with the company's acquisition of biotechnology firm Abcam. Finally, Jim says that this department store stock is the one to be interested in for playing the retail trade.

Persons: Cramer, it's, Jim Organizations: Charitable Trust

☆ Friday, Nov. 17 2023: Cramer says this Big Bank stock remains a buy
▼ + stars: | 2023-11-17 | by ( Sean Conlon | ) www.cnbc.com time to read: 1 min

Friday, Nov. 17 2023: Cramer says this Big Bank stock remains a buyJim and Jeff discuss why they believe there's an opportunity to add to this bank position in the Charitable Trust right now. Jim also says people have forgotten about this life sciences and medical holding ahead of the company's expected acquisition of Abcam next month. Finally, Jim explains why people tend to start buying this construction stock in a bull market.

Persons: Cramer, Jeff, Jim Organizations: Big Bank, Trust Locations: Abcam

☆ How Danaher's new acquisition will boost earnings for the life sciences firm
▼ + stars: | 2023-11-17 | by ( Jeff Marks | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer holds a Morning Meeting livestream at 10:20 a.m. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Danaher, Eli Lilly, Lilly, Jim Cramer's, Jim Organizations: CNBC, Treasury, West Texas, Coterra Energy, Club Locations: Germany, U.S

We're buying 30 shares of Danaher (DHR) at roughly $199 each. Following Tuesday's trade, Jim Cramer's Charitable Trust will own 550 shares of DHR, increasing its weighting in the portfolio to 4.08% from 3.87%. Danaher reported a better-than-expected third-quarter Tuesday morning, but the stock is under pressure in early trading due to uncertainty around the recovery in its bioprocessing business. We kept the shares of Veralto that we received as owners of DHR stock. Jim waits 45 minutes after sending a trade alert before buying or selling a stock in his charitable trust's portfolio.

Persons: Jim Cramer's, Danaher, Bioprocessing, Sartorious, Sartorius, Jim Cramer, Jim Organizations: DHR, Sciences, Stocks, Management, CNBC, Traders, New York Stock Exchange, NYSE Locations: Danaher

☆ Why we bought more Danaher even after it lowered the forecast for a key business
▼ + stars: | 2023-10-24 | by ( Zev Fima | ) www.cnbc.com time to read: +6 min

But shares of the life sciences and medical diagnostics company remain under pressure after management was forced to lower expectations for one of its key businesses. We used Tuesday's sell-off in Danaher shares to add to our position . Driving this forecast is an expectation for biotechnology sales drop in the mid-20% range, life sciences sales to decline by mid-single digit percentage points, and for diagnostics to be down about 20%. Assuming no additional headwinds in the fourth quarter, management reiterated their full year outlook for the bioprocessing base business to be down 10% on a full-year basis. The life sciences unit was hampered by pressure in the instruments business.

Persons: hasn't, Rainer M, Blair, Sartorius, Danaher, Jim Cramer's, Jim Cramer, Jim, Virginia Sherwood Organizations: Revenue, Guidance Management, Management, CNBC, NYSE Locations: Bioprocessing, Danaher, China, Veralto

☆ It's time to get bullish on this health tech name, now that it's shed a drag on growth
▼ + stars: | 2023-10-04 | by ( Zev Fima | ) www.cnbc.com time to read: +8 min

In the separation , we decided to keep the 173 shares of Veralto we received due to our ownership of 520 shares of Danaher. When we do that, we see a very favorable picture heading into next year and three reasons to be bullish. Veralto management is targeting long-term core growth in the mid-single-digit range on a percentage basis, whereas Danaher management sees ex-Veralto growth at a high-single-digit rate over the long term. So, as it stands we're already looking at a business that stands to see overall growth accelerate. It's also worth noting that our portfolio stands to benefit from any growth in the stand-alone shares of Veralto.

Persons: it's, —, haven't, let's, It's, they're, we'll, Danaher, Jim Cramer's, Jim Cramer, Jim, Pavlo Gonchar Organizations: Washington , D.C, Management, Deutsche Bank, Silicon Valley Bank, Federal Reserve, CNBC, Getty Locations: Veralto, Danaher, Washington ,, Silicon

Those potential returns can come from two places: Danaher stock and shares of Veralto (VLTO), the soon-to-be-standalone company that's in the business of water quality. When we receive Veralto shares on Monday, as all Danaher shareholders will, we intend to keep them, based on their current expected value. A "when-issued" market was established Wednesday for both Danaher and Veralto stock, providing a first look at how investors are valuing the companies on their own. Investors will receive one share in Veralto for every three shares of Danaher they own. The caveat is that spin-off debuts can see substantial volatility, and if Veralto shares were to receive a big pop, our discipline may require us to capitalize on that and take profits.

Persons: it's, Danaher, Jim Cramer, Jim Cramer's, Veralto, we'll, –, disinfect, That's, we've, attractively, We're, Jim, Pavlo Gonchar Organizations: Deutsche Bank, Zebra Technologies, CNBC, Getty Locations: Veralto, Danaher, DHR, Wells, York

☆ Health care has had a tough year. Where we stand on our 5 stocks in the sector
▼ + stars: | 2023-09-22 | by ( Kevin Stankiewicz | In Kevinstankiewicz | ) www.cnbc.com time to read: +12 min

Bausch Health (BHC) is a different case. Key points Health-care stocks outperformed the broader U.S. stock market last year, but this year it's been much-tougher sledding for the sector due to a variety of headwinds. We feel comfortable owning our three other primary health care stocks: GE Healthcare, Humana and Danaher. In recent weeks, analysts at Wells Fargo and Citigroup have started coverage of GE Healthcare with buy ratings. The analysts at Jefferies now rate Bausch Health stock a buy, with a price target increase to $16 per share from $9.

Persons: There's Eli Lilly, Eli Lilly, That's, Eli Lilly's, Ryan Issakainen, we're, Issakainen, –, Stryker, Jim Cramer, it's, Jim, We've, Bausch, BHC, We're, I'm, Jefferies, Jim Cramer's, Frederick Florin Organizations: GE Healthcare, Health, Federal Reserve, First Trust Advisors, Humana, Medicare, Dow, UnitedHealth, GE, General Electric, —, Citigroup, Jefferies, CNBC, AFP, Getty Locations: what's, China, STE, Biogen, Wells, Bausch, Fegersheim, France

A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. Catalent named three pharma industry executives and a senior Elliott executive to its board and said John Greisch, who has served on the board since 2018, will become executive chairman. Elliott, whose stake in Catalent became public last month, has been engaging with the company behind the scenes for months. Two of the directors were picked by Elliott, while two were mutually agreed by Elliott and Catalent. Catalent is also forming a new strategic and operational review committee which Greisch will chair.

Persons: Yves Herman, Elliott, Catalent, Alessandro Maselli, John Greisch, Max, William Blair, Maselli, Steven Barg, Goldman Sachs, Frank D'Amelio, Stephanie Okey, Michelle Ryan, Greisch, Merck KGaA, Svea Herbst, Bayliss, Maggie Fick, Sriparna Roy, Shinjini Ganguli, Catherine Evans, Mike Harrison Organizations: REUTERS, Catalent Inc, Elliott Investment Management, Reuters, Novo, pharma, U.S . Food, Drug Administration, Pfizer, Johnson, Catalent, Svea, Thomson Locations: Brussels, Belgium, ., Danish, Novo, United States, Catalent, GLP, Boston, London, Bengaluru

☆ These are the top 10 things to watch in the stock market Tuesday
▼ + stars: | 2023-08-29 | by ( Jeff Marks | ) www.cnbc.com time to read: +4 min

Oracle (ORCL) upgraded to buy from neutral at UBS with a price target of $140. Piper Sandler increases its Broadcom (AVGO) price target to $925 from $830 ahead of earnings Thursday after the bell. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: telco, Corie Barry, Piper Sandler, Bernstein, Jim Cramer's, Jim Cramer, Jim, Marlena Sloss Organizations: Oracle, UBS, Nvidia, Investing, Nasdaq, Verizon, Citi, underperform, Biden Administration, Medicare, pharma, DuPont, Broadcom, Jim Cramer's Charitable, CNBC, Bloomberg, Getty Locations: Airbnb, Salesforce, San Francisco , California

A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. The sources declined to be identified because the information is confidential and cautioned a deal could still collapse at the last minute. Spokespeople for Catalent and Elliott declined to comment. In the past when Elliott has pushed for sales of pieces or the entire target company, including at eBay and Switch Inc., and then won board representation, significant ownership changes have followed. Novo Nordisk's weight-loss drug Wegovy is filled by Catalent’s Brussels factory and last week Reuters reported that Catalent’s plant in Bloomington, Indiana will begin filling Wegovy injection pens for Novo.

Persons: Yves Herman Acquire, Elliott, Catalent, Elliott isn't, Keith Meister's, Scott Ferguson's, Mauricio Gutierrez, Svea Herbst, Bayliss, Maggie Fick, Shri Navaratnam Organizations: REUTERS, Catalent, Elliott Investment Management, AstraZeneca, Johnson, Moderna, eBay, Inc, Deutsche Bank, Management, Capital Management, Reuters, NRG, Svea, Thomson Locations: Brussels, Belgium, U.S, Bloomington , Indiana, Novo, Boston, London

☆ Medical tech firm Danaher to buy Abcam in $5.7 bln deal
▼ + stars: | 2023-08-28 | by ( ) www.reuters.com time to read: +2 min

Aug 28 (Reuters) - Danaher Corp (DHR.N) said on Monday it would buy smaller rival Abcam Plc in an all-cash deal valued at $5.7 billion including debt, as the medical tools supplier expands its services to capture bigger contracts. The deal will help Danaher cushion the hit from sluggish demand for its products such as antibodies and sample preparation equipment from smaller biotech companies that are grappling with a funding crunch. Danaher, one of the world's largest suppliers of medical tools, has already cut its annual sales growth forecast multiple times this year. "This is a nice tuck in deal for Danaher that checks all the boxes. Reuters reported on Friday that Danaher was in the lead to acquire Abcam.

Persons: Vijay Kumar, Danaher, Jonathan Milner, Manas Mishra, Shounak Dasgupta, Sriraj Organizations: Danaher, Abcam Plc, Reuters, Bloomberg, Electric, Thomson Locations: Cambridge, England, Bengaluru

☆ Stocks making the biggest moves premarket: 3M, CrowdStrike, Xpeng and more
▼ + stars: | 2023-08-28 | by ( Hakyung Kim | ) www.cnbc.com time to read: +2 min

Xpeng — U.S.-traded shares of the Chinese electric vehicles company jumped 5% Monday premarket. Xpeng announced it would buy Didi's smart electric car business in a deal worth $744 million. Mister Car Wash — The car wash stock climbed 5.7% in premarket trading following an upgrade to overweight from neutral by Piper Sandler. The firm said Mister Car Wash has upside potential over the next two years. CrowdStrike — Shares of the cybersecurity company fell 2.6% in premarket trading after Morgan Stanley downgraded CrowdStrike to equal weight from overweight.

Persons: Xpeng, Piper Sandler, CrowdStrike, Morgan Stanley, Akero, Conor Flynn, Danaher, —, Jesse Pound, Sarah Min, Alexander Harring Organizations: Shanghai International Automobile Industry, National Exhibition, Convention Center, —, Bloomberg News, UBS, RPT, Kimco Realty, Boston, Boston Scientific Locations: Shanghai, China, Xpeng —

A general view of the drug product manufacturing laboratory in biologics and sterile injectables, Catalent, in Brussels, Belgium June 27, 2023. Spokespeople for Catalent and Elliott declined to comment. The U.S.-based contract drugmaker is also Danish company Novo Nordisk's (NOVOb.CO) main manufacturing partner for its popular weight-loss drug Wegovy. The volatility at Catalent could increase scrutiny on the relationship between Novo and its partner. Reuters reported last week that a second Catalent factory will begin filling Wegovy injection pens for Novo as part of an expanded supply agreement.

Persons: Yves Herman Acquire, Elliott, drugmaker, Markus Manns, Catalent, Elliott isn't, Keith Meister's, Scott Ferguson's, Mauricio Gutierrez, Svea Herbst, Bayliss, Maggie Fick, Amanda Cooper, Shri Navaratnam, Bernadette Baum, Catherine Evans Organizations: REUTERS, Elliott Investment Management, Catalent, Novo, Reuters, Union Investment, AstraZeneca, Johnson, Moderna, eBay, Inc, Deutsche Bank, Management, Capital Management, NRG, Svea, Thomson Locations: Brussels, Belgium, U.S, Danish, Novo, United States, Germany, Boston, London

☆ This life-sciences leader continues to demonstrate a nimble M&A strategy
▼ + stars: | 2023-08-28 | by ( Jeff Marks | ) www.cnbc.com time to read: +2 min

Every weekday the CNBC Investing Club with Jim Cramer holds a Morning Meeting livestream at 10:20 a.m. Equities rise Watch Danaher's portfolio A flurry of trades 1. As a subscriber to the CNBC Investing Club with Jim Cramer, you will receive a trade alert before Jim makes a trade. THE ABOVE INVESTING CLUB INFORMATION IS SUBJECT TO OUR TERMS AND CONDITIONS AND PRIVACY POLICY , TOGETHER WITH OUR DISCLAIMER . NO FIDUCIARY OBLIGATION OR DUTY EXISTS, OR IS CREATED, BY VIRTUE OF YOUR RECEIPT OF ANY INFORMATION PROVIDED IN CONNECTION WITH THE INVESTING CLUB.

Persons: Jim Cramer, Jerome Powell's, Danaher, Estee Lauder, Walt Disney, Jim Cramer's, Jim Organizations: CNBC, Federal, Treasury, West Texas, Micro Devices, Broadcom, GE HealthCare Technologies, Starbucks, Jim Cramer's Charitable Locations: Jackson Hole , Wyoming, Danaher

☆ Starboard Value’s Jeffrey Smith, who's bullish on A.I., reveals his top picks in latest 13F
▼ + stars: | 2023-08-14 | by ( Yun Li | ) www.cnbc.com time to read: +2 min

Starboard Value's Jeffrey Smith has called artificial intelligence "an enormous opportunity," and there are hints of his enthusiasm in his latest, quarterly 13F filing to SEC. The activist investor drastically increased his stake in Wix.com , making it his ninth-biggest holding at the end of June. The hedge fund manager said there's more room for Salesforce to grow and the stock can rally another 30% on the back of the AI boom. Nine years later he spun out his New York-based hedge fund and became the CEO. The hedge fund manager also added a relatively small stake in British life science company Abcam PLC last quarter.

Persons: Jeffrey Smith, Wix.com, Smith, There's, blockchain, there's, Splunk Organizations: SEC, Acacia Research, CNBC, Abcam Locations: Wix.com, Salesforce, New York

Search resuls for: "Abcam"

20 mentions found